zotizalkib   Click here for help

GtoPdb Ligand ID: 12388

Synonyms: TPX-0131 | TPX0131
Compound class: Synthetic organic
Comment: This is the chemical structure for the INN zotizalkib, It maps via PubChem to the lead anaplastic lymphoma kinase (ALK) inhibitor TPX-0131 [1]. TPX-0131 is orally bioavailable, and crosses the blood-brain barrier in a preclinical model.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 80.99
Molecular weight 447.15
XLogP 4.31
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FC([C@@H]1COc2c3N1Cc1cc(F)ccc1OCC(NC(=O)c1c(n3)n(c2)nc1)(C)C)F
Isomeric SMILES CC1(COc2c(CN3[C@@H](COc4cn5c(c(cn5)C(=O)N1)nc34)C(F)F)cc(cc2)F)C
InChI InChI=1S/C21H20F3N5O3/c1-21(2)10-32-15-4-3-12(22)5-11(15)7-28-14(17(23)24)9-31-16-8-29-18(26-19(16)28)13(6-25-29)20(30)27-21/h3-6,8,14,17H,7,9-10H2,1-2H3,(H,27,30)/t14-/m0/s1
InChI Key ILAMRXVQSGVCJX-AWEZNQCLSA-N
References
1. Murray BW, Zhai D, Deng W, Zhang X, Ung J, Nguyen V, Zhang H, Barrera M, Parra A, Cowell J et al.. (2021)
TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations.
Mol Cancer Ther, 20 (9): 1499-1507. [PMID:34158340]
2. Ou SI, Nagasaka M, Brazel D, Hou Y, Zhu VW. (2021)
Will the clinical development of 4th-generation "double mutant active" ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?.
Transl Oncol, 14 (11): 101191. [PMID:34365220]